Overview
MT1 is a targeted peptide analog designed for in vitro and laboratory‑based research involving melatonin receptor type 1 (MT1) signaling pathways. It is widely utilized in studies examining circadian‑rhythm regulation models, neuroendocrine signaling, and peptide–receptor binding dynamics. MT1 is of particular interest for research focused on the biochemical mechanisms associated with the suprachiasmatic nucleus (SCN) and melatonin‑mediated regulatory pathways.
Molecular Characteristics
Peptide Type: Melatonin‑receptor–targeting peptide analog
Form: Lyophilized powder
Purity: ≥ 98% (HPLC)
Storage: –20°C recommended
Research Applications
MT1 is commonly investigated in controlled laboratory environments for:
MT1 receptor‑binding studies
Circadian‑rhythm pathway analysis
Assay development involving neuroendocrine signaling
In vitro modeling of SCN‑associated biochemical processes
Peptide‑mediated receptor‑activation pathway exploration
(Fields of Inquiry. Not biological outcomes.)
Mechanistic Notes (Research Context Only)
In laboratory settings, MT1 is studied for its interaction with:
Melatonin receptor type 1 (MT1) signaling pathways
Circadian‑regulation models involving the SCN
Neuroendocrine‑associated biochemical cascades
Cellular‑response mechanisms linked to melatonin‑mediated signaling
These statements describe mechanistic interest, not biological effects in humans or animals.
Storage & Handling
Store lyophilized peptide at –20°C
Avoid repeated freeze–thaw cycles
Handle reconstituted solutions according to institutional laboratory protocols
Important Research Notice
For laboratory research use only
Not for human consumption
Not a drug, food, or cosmetic
Not for veterinary or household use
No medical, therapeutic, or sleep‑related claims are made